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TITLE: Red wine consumption is associated with fecal microbiota and 1 
malondialdehyde in a human population.  2 
ABSTRACT 3 
Objectives: Red wine intake has been associated with a lower risk of cardiovascular 4 
disease, its polyphenol content being the primary cause of antioxidant and anti-5 
inflammatory properties attributed to this beverage. However, the way in which these 6 
activities are exerted is not yet clear, although some authors have proposed that 7 
intestinal microbiota could be implicated. Methods: The association between red wine 8 
intake, inflammation and oxidative stress parameters and fecal microbial populations 9 
has been explored in 38 adult volunteers. Food intake was recorded by means of an 10 
annual food frequency questionnaire (FFQ). Energy, cholesterol and ethanol intake were 11 
analyzed using the nutrient Food Composition Tables developed by CESNID and 12 
polyphenol intake was obtained from the Phenol-Explorer Database. Fecal levels of 13 
Akkermansia, Bacteroides, Bifidobacterium, Blautia coccoides group, Clostridium 14 
leptum group, Lactobacillus group and Faecalibacterium prausnitzii were determined 15 
by quantitative PCR. Serum concentrations of C-reactive protein (CRP), 16 
malondialdehyde (MDA), total antioxidant capacity (TAC), cholesterol, triglycerides 17 
and glucose were analyzed by standard methods. Results: Subjects with regular 18 
consumption of red wine (mean = 100 ml/day) had lower serum concentrations of MDA 19 
and lower fecal levels of B. coccoides, C. leptum, Bifidobacterium and Lactobacillus. A 20 
positive association between MDA levels and B. coccoides and Lactobacillus was also 21 
found. Conclusion: Regular consumption of red wine appears to be associated with a 22 
reduced serum lipoperoxidation in which the intestinal microbiota may be involved.  23 
24 
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 INTRODUCTION  25 
In the last few decades, several studies have suggested that a moderate consumption of 26 
red wine, which is characteristic of some dietary patterns such as the Mediterranean 27 
one, is an important factor in the prevention of several pathologies related to oxidative 28 
stress [1]. Besides its alcohol content, the moderate intake of which has been related to a 29 
positive effect on health [2], red wine provides other components with additional 30 
benefits beyond those of alcohol alone [3,4]. Red wine is a natural food source of 31 
antioxidants, among which, are phenolic compounds, especially flavonoids, lignans and 32 
stilbenes, contained in the skins and seeds of red grapes [5]. Apart from the effects that 33 
these phenolic compounds exert on the organoleptic properties of this alcoholic 34 
beverage, some authors have proposed their antioxidant capacity as the main reason for 35 
the beneficial health effects ascribed to the moderate consumption of red wine [6,7]. In 36 
this way, Estruch et al. found lower levels of plasma biomarkers of oxidative stress in 37 
healthy men after the consumption of red wine, compared with those consuming gin [8]. 38 
Other authors did not only find lower levels of oxidative stress with the intake of this 39 
beverage, but also higher levels in antioxidant defense [8,9]. Nevertheless, the way in 40 
which red wine exerts its antioxidant actions is not clear. Evidence from animal and 41 
human studies suggests that supplementation with polyphenol-rich foods, such as red 42 
wine could also differentially influence the intestinal bacterial populations, which have 43 
been reported to be responsible of the transformation of these compounds into other 44 
with a higher bioavailability and bioactivity [10]. In this context, the aim of this work is 45 
to bear out the association between the regular consumption of red wine and some 46 
biomarkers of antioxidant status, lipid peroxidation and inflammation, as well as to 47 
analyze the existence of differences in the intestinal microbiota according to the 48 
consumption of this beverage.   49 
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MATERIALS AND METHODS 50 
Participants 51 
The study sample involved 38 healthy adults (27 females, 11 males; aged from 55 to 67 52 
years old). Exclusion criteria were: previous diagnosis of cancer, autoimmune or 53 
digestive diseases and consumption of vitamin or mineral supplements, 54 
probiotics/prebiotics or antibiotics, during the previous month. Ethical approval was 55 
obtained from the Regional Ethical Committee of Asturias and an informed written 56 
consent was obtained from each volunteer.  57 
Nutritional Assessment  58 
Dietary intake was assessed by means of an annual semi-quantitative food frequency 59 
questionnaire (FFQ), detailing 160 items. Trained dieticians asked about cooking 60 
practices, number and quantity of ingredients used in each recipe (e.g., type of oil or 61 
milk used) and other information relevant to the study, such as the consumption of skin 62 
in fruits. During an interview, subjects were asked item-by-item whether they usually 63 
ate each food and, if so, how much they usually ate. For this purpose, 3 different serving 64 
sizes of each cooked food were presented in pictures to the participants so that they 65 
could choose from up to 7 serving sizes (from “less than the small one” to “more than 66 
the large one”). For some of the foods consumed, amounts were recorded in household 67 
units, by volume, or by measuring with a ruler. To record the consumption of alcoholic 68 
beverages, each participant was asked if they consumed them regularly, and if so, they 69 
were asked about the type and amount, for which household measures, such as a glass, a 70 
bottle, etc., were used. Methodological issues concerning dietary assessment have been 71 
detailed elsewhere [11]. Food intake was analyzed for energy, cholesterol and ethanol 72 
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content by using the nutrient Food Composition Tables developed by CESNID [12]. 73 
Polyphenol content was obtained from Phenol-Explorer Database [13]. 74 
Height was registered by using a stadiometer with an accuracy of ±1 mm (Año-Sayol, 75 
Barcelona, Spain). Subjects were barefoot, in an upright position and with the head 76 
positioned in the Frankfort horizontal plane. Weight was measured on a scale with an 77 
accuracy of ± 100 g (Seca, Hamburg, Germany). Body mass index (BMI) was 78 
calculated from the formula weight (kg) /height (m)
 2
. 79 
Microbiological and Biochemical Analyses 80 
Each volunteer was asked to provide a fecal sample and a blood sample directly after 81 
the nutritional assessment period. Blood samples were drawn after a 12-hour fast and 82 
subsequently centrifuged and divided in aliquots. These biological samples were 83 
immediately frozen at -80 °C and stored until further analyses.  84 
One gram of fecal sample was used for DNA extraction with the QIAamp DNA stool 85 
mini kit (Qiagen, Hilden, Germany) and the DNA obtained was used for quantification 86 
of the different bacterial populations (Akkermansia, Bacteroides, Bifidobacterium, 87 
Blautia coccoides group, Clostridium leptum group, Lactobacillus group, and 88 
Faecalibacterium prausnitzii) by quantitative polymerase chain reaction as previously 89 
described [14]. 90 
Serum levels of C-reactive protein (CRP) were determined by CRP Human Instant 91 
ELISA (eBioscience, San Diego, C.A).  92 
Malondialdehyde (MDA) concentrations in serum were determined with the 93 
spectrophotometric method of lipid peroxidation LPO-586 (Byoxytech, Oxis 94 
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International, Portland, OR). This kit uses the reaction of a chromogenic reagent with 95 
MDA, without interference from 4-hydroxyalkenals (hydrochloric acid solvent 96 
procedure), in aqueous samples at 45ºC. One molecule of MDA reacts with 2 molecules 97 
of reagent to yield a stable chromophore with maximal absorbance at 586 nm [15]. The 98 
within-run coefficient of variation ranged from 1.2 to 3.4%, depending on the 99 
concentration of MDA.   100 
Total antioxidant capacity (TAC) in serum was determined with the colorimetric assay 101 
P40117 (Innoprot, Innovative Technologies in Biological Systems, Derio, Vizcaya, 102 
Spain). In this method, Cu
2+ 
is converted to Cu
+ 
by both small molecules and protein. 103 
The reduced ion is chelated with a colorimetric probe giving a broad absorbance peak 104 
around 450 nm, proportional to the TAC [16]. 105 
Serum cholesterol was measured using cholesterol oxidase, esterase and peroxidase; 106 
triglycerides by the lipase method; and glucose by the hexoquinase method. All were 107 
analyzed with a DimensionXpand plus (Siemens, Erlangen, Germany) and in an 108 
independent laboratory (Análisis Clínicos Blanco, Gijón, Asturias, Spain).  109 
Statistical Analysis 110 
Statistical analysis was performed using SPSS version 19.0 (SPSS Inc., Chicago, IL). 111 
Data are presented as means ± SD for continuous variables and as percentages for 112 
categorical ones. Goodness of fit to normal distribution was investigated by 113 
Kolmogorov-Smirnov test. Given that the intake of anthocyanins, dihydrochalcones, 114 
dihydroflavonols, flavones, total phenolic acids, hidroxibenzoic and hidroxicinnamic 115 
acids, and stilbenes intake and fecal levels of Clostridium leptum showed a skewed 116 
distribution, they were logarithmically transformed for statistical analysis. All the 117 
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variables included in this work were analyzed according to the intake of red wine. For 118 
this purpose, the sample was divided between those who had consumed red wine during 119 
the previous year and those had not. Thus, a dichotomous variable was created between 120 
non-consumers (n=16) and consumers (n=22) of this beverage. Significant differences 121 
between means were calculated by multivariate-analysis of variance to allow for 122 
covariate adjusting. Gender, body mass index and energy intake were included as 123 
covariates in the model. For descriptive purposes, mean and SD were presented on 124 
untransformed variables. Pearson bivariate correlations between fecal microbial groups 125 
and serum MDA, CRP and TAC were also carried out. The conventional probability 126 
value (0.05) for significance was used in the interpretation of results. 127 
RESULTS 128 
General characteristics of the sample: energy, cholesterol, and ethanol intake; and serum 129 
levels of cholesterol, triglycerides and glucose, together with body mass index and 130 
smoking habit, distributed by red wine consumption, are shown in Table 1. Values of all 131 
the variables evaluated were similar in both samples with the exception of ethanol 132 
intake, which was higher in the red wine consumers.  133 
Daily mean intake of polyphenol classes and subclasses, according to red wine 134 
consumption, is presented in Table 2. The intake of flavonoids and stilbenes was higher 135 
in the consumers. Anthocyanins, dihydroflavonols, and flavanols were the flavonoids 136 
slightly increased in this group of subjects, together with hydroxybenzoic and 137 
hydroxyphenylacetic acids within phenolic acids.   138 
The differences in the fecal levels of intestinal microbial groups as well as in the serum 139 
biochemical parameters between red wine consumers and non-consumers were also 140 
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investigated (Table 3). With regard to the fecal microbial populations, subjects who  141 
consumed red wine regularly had lower levels of Bifidobacterium, B. coccoides, C. 142 
leptum, and Lactobacillus. This group also presented lower serum concentrations of 143 
MDA. No significant differences were found for serum levels of CRP and TAC. 144 
To examine whether fecal microbiota may be associated with the levels of oxidative 145 
stress and inflammation, Pearson bivariate correlations between bacterial groups and 146 
serum parameters were performed (Table 4). A positive association was found between 147 
MDA and B. coccoides and Lactobacillus, whereas no statistically significant 148 
differences were found for MDA and the rest of the microbial groups analyzed or 149 
between these groups and CRP or TAC. 150 
DISCUSSION 151 
In literature, a wide range of beneficial health effects have been attributed to the 152 
moderate consumption of red wine [17]. Our data highlighted that the consumption of 153 
this beverage in the context of a regular diet could be associated with reduced levels of 154 
MDA and hence with lower lipid peroxidation in our human sample. This effect has 155 
been traditionally attributed to the antioxidant capacity of the compounds present in red 156 
wine. However, although red wine consumption contributed to a higher flavonoid, 157 
phenolic acid, and stilbene intake in the sample, this was too low to observe any 158 
differences in the pool of total polyphenol intake between consumers and non-159 
consumers. Accordingly, we did not find differences in serum antioxidant status 160 
between both groups. This finding differs from previous studies reporting a positive 161 
association between red wine intake and total antioxidant capacity in serum [18-20]. In 162 
this regard, some factors should be considered: first, the mean consumption of red wine 163 
in our study (100.07 ml/day) is much lower than the 375-400 ml/day reported by others 164 
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[9,21]; second, it is likely that the effect from supplementation studies with high doses 165 
of red wine during short periods of time (2-4 weeks) has a different effect with respect 166 
to that of regular consumption. It is also likely that the variability in the consumption of 167 
this beverage could exert different effects between subjects. Moreover, it is of special 168 
interest to consider the potential role of the rest of the polyphenols or antioxidants 169 
ingested in the diet because, as we observed in this study, the amount of antioxidants 170 
provided by other food groups, such as fruits or vegetables, could counteract the 171 
differences in the total antioxidant pool between consumers and non-consumers. It 172 
should also be taken into account that the grape variety, cultivation, processing and 173 
ageing of wine can determine the final polyphenol content of red wines [22].  174 
The linkage between red-wine consumption and health is under investigation. MDA is 175 
one of the most abundant products of lipid peroxidation cytotoxins formed in foods or 176 
endogenously and it is probably the most widely used marker of lipid peroxidation in 177 
humans [23,24]. There is no consensus in literature about the usefulness of MDA in 178 
predicting risk of mortality, but comparison with previous studies in other human 179 
populations of serum concentrations of this compound reveal that red wine consumers 180 
in our sample had concentrations of MDA similar to those found in subjects with a 181 
lower risk of mortality [25]. In addition to the impact of red wine on oxidative stress, 182 
light to moderate red wine consumption has also been associated with reduced 183 
inflammation [19]. We have not found significant differences in CRP concentrations 184 
between red wine consumers and non-consumers. Although CRP has been identified by 185 
several authors as significant predictor of cardiovascular events, the concentrations 186 
found in the total of the sample are within the low risk range (0.11-0.55 mg/dl) 187 
previously described [26]. 188 
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Recent studies have indicated that the intestinal microbiota may be responsible, in part, 189 
for the beneficial effects described for red wine polyphenols as the bacterial 190 
modification of these compounds, resulting in metabolites with greater intestinal 191 
absorption than the original phenolic compounds and improved antioxidant activity at 192 
systemic level [27-32]. Some authors have proposed that all individuals have their own 193 
unique signature of intestinal microbiota, the composition of which could be modulated 194 
by long-term changes in diet [31,33,34]. We found that the dominant microbiota in the 195 
feces of the regular red wine consumer and the non-consumer groups was slightly 196 
different. Red wine consumers had lower levels of Blautia coccoides, Clostridium 197 
leptum, Bifidobacterium, and Lactobacillus, which is in accordance with the 198 
antibacterial activity of polyphenols reported in other studies [35-37]. It is probably that 199 
the cell-wall structure of the different bacterial groups could determine their 200 
susceptibility to the antimicrobial effect of phenolic compounds, where gram-positive 201 
bacteria are more sensitive than gram-negative bacteria [38-40]. The levels of 202 
Akkermansia, Bacteroides, and F. prausnitzii were no different between consumers and 203 
non-consumers, suggesting that these microorganisms may be less sensitive to the 204 
“antimicrobial” effect of phenolic compounds or that they may benefit from the 205 
antioxidant activity. Other authors have found increased levels of microbial groups from 206 
Proteobacteria and Fusobacteria after supplementation with this beverage [41]. 207 
Although epidemiological analyses did not establish causality, together with the limited 208 
sample size, the positive correlations observed between MDA and B. coccoides and 209 
Lactobacillus are in agreement with the hypothesis we have put forward regarding the 210 
implication of changes in the microbiota in the beneficial effects attributable to this 211 
beverage. In a future, it will be desirable to extend the sample size in order to increase 212 
the statistical power of the study and to stratify the consumption of red wine in low-213 
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medium-high consumers to deepen in the association between this beverage with the 214 
intestinal microbiota and oxidative stress and to determine whether it is dose dependent. 215 
CONCLUSION 216 
Regular consumption of red wine appears to be associated with a reduced serum 217 
lipoperoxidation in which the intestinal microbiota may be involved.   218 
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Table 1. General characteristics of the study sample according to the consumption of red wine. 
 Non-consumption (N = 16) Consumption (N = 22)
 a
 
Age (y) 61.44 ± 2.58 60.73 ± 3.74 
Male sex (%) 25.0 31.8 
Energy intake (kcal/d) 1798.81 ± 368.74 2022.29 ± 650.16 
Cholesterol intake (mg/d) 282.71 ± 88.23 323.12 ± 141.15 
Ethanol intake (g/d) 2.24 ± 5.00 12.01 ± 9.12 ** 
Serum cholesterol (mg/dl) 237.19 ± 26.12 228.05 ± 44.94 
Serum triglycerides (mg/dl) 113.31 ± 30.82 119.55 ± 64.85 
Serum glucose (mg/dl) 98.63 ± 16.66 97.09 ± 10.61 
BMI (kg/m
2
) 26.26 ± 3.70 25.51 ± 3.18 
Smoking habit (%) 24.4 30.0 
a 
Mean intake of red wine = 100.07 ml/d. 
Results are presented as mean ± SD and percentage (%). 
BMI = Body Mass Index 
** p ≤ 0.001   
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Table 2. Mean intake of polyphenol classes and subclasses according to the consumption of red 
wine. 
  Non-consumption (N = 16) Consumption (N = 22)
 a
 
Total polyphenols (mg/d) 2310.07 ± 1081.53 2364.06 ± 1051.47 
Flavonoids (mg/d) 368.70 ± 196.10 562.61 ± 292.11 * 
Anthocyanins  4.68 ± 11.30 45.72 ± 48.60 * 
Dihydrochalcones  3.39 ± 2.27 2.64 ± 3.11 
Dihydroflavonols  0.83 ± 2.72 5.46 ± 4.34 * 
Flavanols  153.24 ± 133.46 290.26 ± 201.86 * 
Flavanones  148.30 ± 96.77 163.45 ± 206.98 
Flavones  4.40 ± 3.18 4.29 ± 6.27 
Flavonols  53.86 ± 55.24 50.81 ± 32.27 
Phenolic acids (mg/d) 119.37 ± 67.47 197.04 ± 201.48 
Hydroxybenzoic acids 5.53 ± 3.92 25.40 ± 31.80 * 
Hydroxycinnamic acids 113.76 ± 66.04 171.43 ± 190.27 
Hydroxyphenylacetic acids 0.08 ± 0.12 0.21 ± 0.16 * 
Stilbenes (mg/d) 0.56 ± 1.71  3.57 ± 2.76 ** 
Lignans (mg/d) 0.97 ± 0.46 1.02 ± 0.32 
Other polyphenols (mg/d) 10.93 ± 5.16 17.46 ± 13.02 
a
 Mean intake of red wine = 100.07 ml/d. 
Analysis adjusted by gender, body mass index and energy intake.   
Results are presented as estimated marginal means ± SD on untransformed variables. 
* p ≤ 0.05 ** p ≤ 0.001   
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Table 3. Mean values of fecal microbial groups and biochemical parameters according to the 
consumption of red wine. 
 
Non-consumption  
(N = 16) 
Consumption  
(N = 22)
 a
 
Microbial groups (log no. cells/g):    
Akkermansia   6.64 ± 1.93 6.51 ± 1.82  
Bacteroides  9.50 ± 0.64 9.31 ± 0.65 
Bifidobacterium  8.32 ± 0.78  7.89 ± 0.58 * 
Blautia coccoides  8.57 ± 0.86   6.89 ± 1.59 ** 
Costridium leptum  10.02 ± 0.38   9.12 ± 0.82 ** 
Lactobacillus  6.35 ± 1.23   5.49 ± 1.2 * 
Faecalibacterium prausnitzii  6.90 ± 0.77 6.49 ± 0.75 
Biochemical parameters:   
Serum MDA (µM) 2.18 ± 0.44 1.84 ± 0.52 * 
Serum CRP (pg/ml) 1641.53 ± 1293.94 1122.05 ± 1079.37 
Serum TAC (mM) 0.35 ± 0.08 0.33 ± 0.09 
a
 Mean intake of red wine = 100.07 ml/d. 
MDA = Malondialdehyde; CRP = C-Reactive Protein; TAC = Total Antioxidant Capacity 
Analysis adjusted by gender, body mass index and energy intake.  
Results are presented as estimated marginal means ± SD on untransformed variables. 
* p ≤ 0.05 ** p ≤ 0.001   
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Table 4. Pearson bivariate correlations between serum biochemical parameters and fecal microbial 
groups (log no. cells/g) (N = 38)  
 
 
Serum MDA 
(µM) 
Serum CRP 
(pg/ml) 
Serum TAC 
(mM) 
Akkermansia  -0.125 0.203 -0.168 
Bacteroides  -0.067 0.124 -0.126 
Bifidobacterium  0.043 0.125 0.008 
Blautia coccoides   0.443* 0.203 0.170 
Clostridium leptum  0.183 0.192 0.127 
Lactobacillus   0.331* 0.168 0.201 
Faecalibacterium prausnitzii  -0.195 0.085 0.069 
MDA = Malondialdehyde; CRP = C-Reactive Protein; TAC = Total Antioxidant Capacity 
* p ≤ 0.05 
